Evaluation of the Results of Chemotherapy in High Risk Gestational Trophoblastic Tumors with Multidrug EMA-CO Regimen + Granulocyte-Colony Stimulating Factor (G-CSF) Support
Journal Title: International Journal of Contemporary Medical Research - Year 2018, Vol 5, Issue 1
Abstract
Introduction: Among the gynecological malignancies the tumors arising from abnormal fertilization are the GTT. They are of five distinct clinicopathological characteristics, most of them are chemosensitive and curable though some of them metastasize distantly also. EMA-CO regimen provides high remission rate and prolongs survival even in high risk GTT patients, with leucopenia as common side effect. The aim of this study was to complete the treatment within the scheduled time and achieve cure. Material and methods: This is a prospective study of 18 women of high risk gestational trophoblastic tumors evaluated over a period of 4.5 years from February 2008 to August 2012. Only the patients of high risk category were included in this study. They were evaluated for age, duration of amenorrhea, number of deliveries, abortions, the antecedent pregnancy, evacuation for vesicular mole and previous chemotherapy received. All women were put on EMA-CO regimen (EMA+CO = Etoposide, Methotrexate, Actinomycin+ Cyclophophamide and Vincristine). G-CSF 300μ SC was given on D1and D2 to prevent any delay in schedule due to leucopenia. Intrathecal methotrexate was given to patients suspected of brain metastasis and as prophylaxis in women having pulmonary metastasis. Results: Of the 18 patients treated, 16(88.9%) achieved remission with the EMA-CO regimen. None of the chemotherapy cycles were delayed due to leucopenia, which is a major limiting side effect in earlier studies. Other toxicities of chemotherapy were evaluated. Conclusion: In the present study a complete remission and 5 year survival of 89% has been achieved, which is comparable to the previous studies. The response of the treatment in the GTT patients in this region of the world having different demographic features is similar to those of the other parts of the world. Prophylactic use of G-CSF with EMA-CO regimen in treatment of high risk GTT patients is advocated.
Authors and Affiliations
Ravi Byahut, Mithilesh Kumar
Keywords
Related Articles
- EP ID EP428914
- DOI -
- Views 80
- Downloads 0
Assessment of Severity and Systemic Involvement in Chronic Obstructive Pulmonary Disease by Bode Index: A Cross-Sectional Study
Introduction: BODE index is a multidimensional grading system which is based on Body mass index, airway obstruction, Dyspnoea scale, and Exercise capacity, has been in use continuously for the evaluation of chronic obstr...
Anaesthetic Management of A Paediatric Patient with Bilateral Temporomandibular Joint Ankylosis: A Case Report
Introduction: The role of fibreoptic bronchoscopy (FOB) in patients with difficult airway is well established, however in paediatric patients it becomes very difficult due to lack of cooperation and decreased lung reserv...
Study of Bacteriological Profile of Post Operative Wound Infections in Surgical Wards in a Tertiary Care Hospital
Introduction: Surgical site infections (SSIs) are known to be one of the most common causes of nosocomial infections worldwide and account for nearly 20% to 25% of all nosocomial infections. Surgical site infection rates...
Efficacy and Safety of Nd:YAG Laser 1064-nm in the Treatment of Onychomycosis
Introduction: Onychomycosis is a common encounter in skin clinics that has varied oral and topical medications for its treatment. At times, conventional oral regimens might be contraindicated and owing to slow growth rat...
Spectrum of Antimicrobial Sensitivity of Escherichia Coli in Sputum in a Tertiary Medical Centre in Kolkata, West Bengal, 7 Years’ Experience
Introduction: E coli though is a normal inhabitant of human gastrointestinal tract but in case of immunocompromized patients it is responsible for producing different type of diseases involving different systems of the b...